Home/ Stocks/ AURA

Aura Biosciences, Inc. Common Stock

AURA XNAS

$6.31 -0.22 (-3.37%) ▼ 15-min delayed

Open

$6.42

High

$6.52

Low

$6.20

Volume

201.1K

Market Cap

$414.68M

About Aura Biosciences, Inc. Common Stock

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 106 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	N/A	$-26,130,000	$-0.40
Q1 2025	N/A	$-27,483,000	$-0.55
FY 2024	N/A	$-86,919,000	$-1.75
Q3 2024	N/A	$-21,042,000	$-0.42

Related Market News

No specific coverage for AURA yet. Check out our latest market news or earnings calendar.

Get AURA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Aura Biosciences, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.